Relmada Therapeutics shares owned by Summit Investment Advisors
Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by Summit Investment Advisors
from 13F filings
Historical chart of Summit Investment Advisors investment in Relmada Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Relmada Therapeutics held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Relmada Therapeutics by Summit Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-06-30 | $59k | 8.6k | 6.92 |
| 2023-03-31 | $4.4k | 1.9k | 2.26 |
| 2022-12-31 | $8.5k | 1.9k | 4.42 |
| 2022-09-30 | $71k | 1.9k | 36.86 |
| 2022-06-30 | $36k | 1.9k | 18.69 |
| 2022-03-31 | $52k | 1.9k | 27.00 |
| 2021-12-31 | $28k | 1.2k | 22.54 |
| 2021-09-30 | $33k | 1.2k | 26.57 |
| 2021-06-30 | $40k | 1.2k | 32.21 |
| 2021-03-31 | $44k | 1.2k | 35.43 |
| 2020-12-31 | $40k | 1.2k | 32.21 |
| 2020-09-30 | $47k | 1.2k | 37.84 |
| 2020-06-30 | $56k | 1.2k | 45.09 |
More positions owned by Summit Investment Advisors
View all positions for Summit Investment Advisors